“Osteoprotegerin, C- Reactive protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their potential for Increased incidence of Cardiovascular Disorders”, IJPHRD, vol. 11, no. 8, pp. 206–213, Aug. 2020, doi: 10.37506/ijphrd.v11i8.10923.